Related by context. All words. (Click for frequent words.) 73 ejection fraction 73 left ventricular ejection 71 P = .# 70 left ventricular systolic 70 ejection fractions 70 HbA 1c 69 MACCE 69 binary restenosis 69 NYHA class 69 lumbar spine BMD 69 HbA1c levels 69 MADRS score 68 infarct size 68 NYHA functional class 68 ventricular function 68 intima media thickness 68 liver histology 67 systolic dysfunction 67 echocardiographic 67 atheroma volume 67 periprocedural 67 eGFR 67 CK MB 67 NIHSS 67 median PFS 67 serum creatinine 67 leukocyte count 67 biochemical recurrence 66 systolic function 66 postoperatively 66 #mmHg [001] 66 D dimer 66 hemoglobin A1c levels 66 EDSS score 66 troponin T 66 diameter stenosis 66 definite stent thrombosis 66 coronary revascularization 66 hip BMD 66 LV dysfunction 66 serum creatinine levels 66 nondiabetic patients 66 postoperative complication 66 PSADT 65 fraction LVEF 65 nonfatal MI 65 laboratory abnormalities 65 virologic response 65 left ventricular dysfunction 65 diastolic dysfunction 65 glycated hemoglobin 65 alanine aminotransferase ALT 65 mL/min/#.# m 2 65 LV ejection fraction 65 QTc 65 baseline HbA1c 65 left ventricular LV 65 ≥ 65 QRS duration 65 tirofiban 65 thromboembolic events 65 Ejection Fraction 65 PaO 2 65 dyssynchrony 65 myocardial infarction MI 65 serum potassium 65 FOLFOX4 64 pulmonary capillary wedge 64 repeat revascularization 64 serum phosphate levels 64 MMSE score 64 ejection fraction EF 64 neutrophil counts 64 NATRECOR R 64 preoperatively 64 systolic 64 IPSS 64 HSCT 64 PASI scores 64 QTcF 64 Unified Parkinson Disease 64 Kaplan Meier analysis 64 HOMA IR 64 renal function 64 ipsilateral stroke 64 estimated glomerular filtration 64 glomerular filtration rate 64 aspartate aminotransferase AST 64 ischemic cardiomyopathy 64 glycated hemoglobin HbA1c 64 HbA1c 64 serum IGF 64 mIU L 64 myocardial infarction 64 creatinine clearance 64 fasting plasma glucose 64 EDSS scores 64 coronary stenosis 64 reinfarction 64 Index CDAI 64 oxycodone CR 64 symptomatic VTE 64 OPCAB 64 radical nephrectomy 64 NYHA 64 β blockers 64 beta blocker therapy 64 p = #.# [002] 64 Hb A1C 64 reintervention 64 systolic BP 63 thyroglobulin 63 lumbar spine bone 63 perioperative mortality 63 Thrombolysis 63 revascularization 63 ALND 63 morphometric vertebral fractures 63 UACR 63 SGRQ 63 composite endpoint 63 alanine aminotransferase 63 serum urate 63 mm Hg 63 eplerenone 63 ventricular dysfunction 63 HDRS 63 VT VF 63 mitral regurgitation 63 hsCRP levels 63 mL kg 63 reoperation 63 PSA nadir 63 virologic failure 63 carotid intima media 63 ventricular mass 63 revascularization procedures 63 carotid stenosis 63 EBRT 63 pCR 63 endarterectomy 63 fasting insulin 63 serum phosphate 63 preoperative PSA 63 tolvaptan 63 SCr 63 tiotropium 63 TAXUS Express Stent 63 glycated hemoglobin levels 63 p = .# [002] 63 unfractionated heparin 63 NIHSS score 63 NT proBNP 63 femoral neck BMD 63 nonfatal myocardial infarction 63 cerebrovascular events 63 arterial thromboembolic events 63 ADAS cog 63 hemoglobin Hb 63 preserved ejection fraction 63 Psoriasis Area 63 achieved ACR# 63 abciximab 63 creatinine levels 63 mg BID 63 postintervention 63 multivessel disease 63 μmol L 63 tenecteplase 63 thromboembolic 63 HbA 1c levels 62 XIENCE V PROMUS Stent 62 serum ALT 62 aminotransferases 62 hsCRP 62 extrapyramidal symptoms 62 ng dL 62 Operative mortality 62 statistically significant p = 62 sinus rhythm 62 FEV1 62 serum sodium 62 creatine kinase MB 62 #.#/#.# mmHg [001] 62 subtrochanteric 62 glomerular filtration 62 colorectal adenoma 62 elevated LDH 62 endometrial thickness 62 HBeAg seroconversion 62 microalbuminuria 62 carotid IMT 62 Median survival 62 SUVmax 62 CYPHER Stent 62 aortic regurgitation 62 lopinavir r arm 62 antihypertensive medications 62 lobectomy 62 HAQ DI 62 retinal thickness 62 placebo dexamethasone 62 alteplase 62 diastolic BP 62 multivariable analysis 62 platelet reactivity 62 irbesartan 62 serum calcium levels 62 Left Ventricular Ejection Fraction 62 UPDRS 62 aspartate aminotransferase 62 % Confidence Interval 62 severe neutropenia 62 proteinuria 62 target vessel revascularization 62 severe exacerbations 62 Taxus Stent 62 urinary N telopeptide 62 Montgomery Asberg Depression 62 stable angina 62 5FU 62 bypass graft CABG surgery 62 pg mL 62 cTnI 62 hypoperfusion 62 MMSE scores 62 recurrent VTE 62 carotid artery stenosis 62 bypass grafting 62 lipid lowering therapy 62 revascularizations 62 histologically 62 mL/min/#.# m2 62 hemodynamics 62 lymphadenectomy 62 Baseline characteristics 62 QTc interval 62 mg kg dose 62 % CI #.#-#.# [006] 62 #.#ng/ml 62 mm Hg systolic 62 NSTE ACS 61 ventricular ejection fraction 61 Ishak fibrosis score 61 systemic embolism 61 A1C levels 61 baseline A1C 61 cerebral perfusion 61 myocardial ischemia 61 sweat chloride 61 TACE 61 inotropic 61 highest tertile 61 azacitidine 61 recurrent ischemia 61 clinically meaningful improvement 61 nonsignificant 61 NSTEMI 61 % CI #.#-#.# [003] 61 candesartan 61 myocardial viability 61 mmHg diastolic 61 6MWD 61 myocardial perfusion 61 ischemia driven 61 diastolic function 61 IIIa inhibitor 61 nicardipine 61 crossclamp 61 elevated ALT 61 Left ventricular ejection 61 creatinine ratio 61 CABG 61 apnea hypopnea index 61 ng mL 61 sUA 61 mmHg 61 #mm Hg 61 anemia hemoglobin 61 lispro 61 p = #.# [004] 61 hematologic toxicity 61 4mg/kg 61 macroalbuminuria 61 serum phosphorus 61 perioperative complications 61 eptifibatide 61 FDG uptake 61 rCBF 61 myocardial infarctions 61 fasting glucose 61 euthyroid 61 CCyR 61 Crohn Disease Activity 61 valsartan 61 CI -#.# 61 timepoints 61 asymptomatic carotid stenosis 61 transaminase elevations 61 preoperative chemotherapy 61 graft occlusion 61 intravesical therapy 61 pulsatile flow 61 femoral shaft fracture 61 nonresponders 61 certolizumab 61 thromboembolism 61 μg L 61 femoral neck 61 nephrectomy 61 gadolinium enhancing lesions 61 endoscopic remission 61 enoxaparin 61 hypertensives 61 ATACAND 61 leukopenia 61 % CI #.#-#.# [007] 61 g dL 61 CR nPR 61 infarcts 61 AST ALT 61 CTEPH 61 x ULN 61 TEAEs 61 tamsulosin 61 biochemical relapse 61 Serum creatinine 61 glycosylated hemoglobin 61 fondaparinux 61 patency 61 Stent thrombosis 61 nonoperative 61 target lesion revascularization 61 glycoprotein IIb IIIa inhibitors 61 undetectable HBV DNA 61 postprocedure 60 Postoperative 60 primary patency 60 receiving VICTRELIS 60 Montgomery Åsberg Depression 60 ropivacaine 60 adrenalectomy 60 plasma uric acid 60 infarctions 60 pioglitazone 60 pulmonary artery pressure 60 lactate dehydrogenase LDH 60 paroxysmal AF 60 ICD implantation 60 cardiovascular mortality 60 placebo p = 60 5-FU/LV 60 #Gy 60 #mg BID [003] 60 nadolol 60 pulmonary artery banding 60 lymphocyte counts 60 vertebral fractures 60 BENICAR HCT 60 transaminases 60 bosentan 60 prospectively defined 60 postop 60 intraocular pressure IOP 60 IABP 60 posttransplant 60 glimepiride 60 Events MACE 60 mmHg systolic 60 fractional shortening 60 Rating Scale MADRS 60 hemoglobin A1c HbA1c 60 tertile 60 moderate renal impairment 60 NLX P# 60 troponin 60 graft dysfunction 60 vertebral fracture 60 serum uric acid 60 UPDRS motor 60 adjunctive placebo 60 DAS# scores 60 CrCl 60 graft patency 60 preintervention 60 intracerebral hemorrhage 60 arterial oxygen saturation 60 serum HBV DNA 60 HbA1C levels 60 thrombus aspiration 60 NPH insulin 60 FOLPI 60 NNT = 60 myocardial infarction stroke 60 renal insufficiency 60 unstable angina pectoris 60 HbA1C 60 colorectal liver metastases 60 neurologic progression 60 fibrinolytic therapy 60 Primary endpoints 60 advanced adenomas 60 periprocedural MI 60 nonischemic cardiomyopathy 60 noncardiac 60 fibrinolysis 60 chlorambucil 60 glycosylated hemoglobin HbA1c 60 normotensive 60 ARB telmisartan 60 transaminase levels 60 colectomy 60 serum testosterone 60 pegylated interferon alfa 2b 60 distant metastases 60 mcg BID 60 LV hypertrophy 60 pg ml 60 dobutamine 60 neostigmine 60 nonobstructive CAD 60 carotid artery intima media 60 CsA 60 renal dysfunction 60 placebo p 60 HbA 1C 60 ximelagatran 60 #.#mg/dL 60 postoperative complications 60 RVOT 60 annualized relapse 60 mean baseline HbA1c 60 intact parathyroid hormone 60 postoperative mortality 60 diastolic blood pressures 60 DAPT 60 nmol liter 60 discontinuations due 60 LDL C 60 prespecified 60 squamous histology 60 reach statistical significance 60 cardiogenic shock 60 serum PTH 60 hs CRP 60 echocardiographic parameters 60 WOMAC scores 60 chemoradiotherapy 60 serum calcium 60 peak VO2 60 T2DM 60 alkaline phosphatase 60 paricalcitol 60 tapentadol ER 60 thrombotic events 60 Hb levels 60 PCWP 60 refractory ischemia 60 hippocampal volume 60 p = 60 albuminuria 60 LVSD 60 FOLFIRI 60 pneumonectomy 60 mcg Albuferon 59 nonoperative treatment 59 ischemic stroke 59 lumen diameter 59 mcg kg 59 primary aldosteronism 59 inotropic therapy 59 diastolic heart 59 TAVR 59 DMARD 59 IV NSCLC 59 CDAI 59 DAS# [002] 59 ACR# response 59 fasting blood glucose 59 hemodilution 59 VcMP 59 CI #.#-#.# [001] 59 daunorubicin 59 carotid plaque 59 nonischemic 59 hemoglobin A1C 59 nodal metastases 59 free survival PFS 59 Free Survival PFS 59 insulin glargine 59 rosuvastatin #mg 59 sirolimus eluting stent 59 dose cytarabine 59 partial remissions 59 subclinical hypothyroidism 59 mTSS 59 contractile function 59 elevated troponin 59 NYHA Class II 59 serum triglycerides 59 A1c levels 59 paraprotein 59 intravenous diuretics 59 fasting glucose levels 59 T2 lesions 59 splenectomized patients 59 gout flares 59 neoadjuvant chemotherapy 59 patients undergoing CABG 59 EDSS 59 etanercept 59 arterial stiffness 59 CABG surgery 59 adenoma recurrence 59 adalimumab 59 Hazard Ratio 59 CD4 + cell 59 abdominal circumference 59 serum HCV RNA 59 IBDQ 59 clinically meaningful improvements 59 mineral density 59 TAXUS Stent 59 mg/m2 dose 59 advanced adenoma 59 HAM D# scores 59 ventricular dilatation 59 white matter hyperintensities 59 nmol L 59 hydroxyvitamin D levels 59 QTc prolongation 59 sd = 59 fosamprenavir 59 locoregional recurrence 59 univariate analysis 59 cerebral infarction 59 lung metastases 59 rFVIIa 59 stenosis 59 lowest tertile 59 renal artery stenosis 59 sirolimus stent 59 mcg QD 59 hemodynamic parameters 59 GnRH agonist 59 thromboembolic complications 59 TAXUS stent 59 everolimus eluting stents 59 TURBT 59 mCi 59 cytogenetic abnormalities 59 hemodialysis patients 59 HCV RNA 59 myocardial reperfusion 59 oral antidiabetic medication 59 Cypher Stent 59 undergoing coronary artery 59 IFN α 59 nonvertebral fracture 59 comparator arm 59 methotrexate monotherapy 59 cTnT levels 59 transthoracic 59 angiographic restenosis 59 hemoglobin concentrations 59 pT3 59 pegylated liposomal doxorubicin 59 paclitaxel eluting stents 59 log# copies mL 59 pmol L 59 percutaneous intervention 59 angiotensin converting enzyme inhibitors 59 ADAS Cog 59 Negative Syndrome 59 left ventricular diastolic 59 mucosal healing 59 TIMP 1 59 hemodynamic instability 59 serum estradiol 59 treated nonoperatively 59 mcg mL 59 FOLFOX 59 bivalirudin 59 serum PSA 59 corrected QT interval 59 mycophenolate mofetil 59 neurocognitive function 59 tumor recurrence 59 fasting plasma glucose FPG 59 ventricular dilation 59 recanalization 59 adenoma 59 Alzheimer Disease Assessment 59 plain radiographs 59 occlusive disease 59 CR CRu 59 n = 59 bivalirudin monotherapy 59 cerebral oxygenation 59 unfractionated heparin UFH 59 underwent CABG 59 serum phosphorous 59 confidence interval CI 59 evaluable subjects 59 achieved statistical significance 59 afterload 59 mechanical dyssynchrony 59 Cmax 59 locoregional 59 noninferiority 59 p = #.# [003] 59 Hb 59 evaluable 59 febrile neutropenia 59 fractional anisotropy 59 mL min 59 NYHA Class III 59 Lucentis monotherapy 59 neointimal hyperplasia 59 plus MTX 59 events MACE 59 Pred Forte 58 posttreatment 58 mmol L 58 albumin excretion rate 58 Doxil ® 58 mitral stenosis 58 REYATAZ r arm 58 oxygen desaturation 58 p = NS 58 PREZISTA r arm 58 Expanded Disability Status 58 ± SD 58 onset atrial fibrillation 58 nondepressed 58 creatinine 58 plus methotrexate 58 HDL C 58 cTnT 58 #mg BID [001] 58 mg dL 58 CDAI score 58 atherogenic dyslipidemia 58 ventricular dyssynchrony 58 specific antigen PSA 58 underwent resection 58 dose dexamethasone 58 nonvertebral fractures 58 p = .# [001] 58 mEq L 58 deep venous thromboses 58 cholecystectomy 58 abacavir lamivudine 58 ketorolac 58 tumor resection 58 #mg/m# [001] 58 thrombolysis 58 pericardial effusion 58 SGPT 58 electrical cardioversion 58 parathyroidectomy 58 asystole 58 preoperative 58 lymphopenia 58 Secondary endpoints 58 DHCA 58 thrombolytic therapy 58 Score IPSS 58 glycemia 58 postoperative morbidity 58 Subgroup analysis 58 -#.# mg dL [002] 58 aldosterone antagonists 58 reoperations 58 complete cytogenetic response 58 Major Adverse Cardiac 58 WOMAC pain 58 nondiabetic 58 oral allopurinol 58 mmol l 58 cytopenias 58 IFN alfa 58 pulmonary exacerbations 58 Patency 58 metformin monotherapy 58 carotid endarterectomy 58 atrioventricular valve 58 primary percutaneous coronary 58 urinary albumin 58 thrombotic complications 58 pulmonary arterial 58 stenoses 58 uncorrected visual acuity 58 mm Hg diastolic 58 hemoglobin A1c 58 peginterferon 58 secondary endpoint 58 anticoagulation 58 lymphocytosis 58 PCa 58 dacarbazine 58 tricuspid regurgitation 58 electrocardiographic 58 dual antiplatelet therapy 58 non valvular atrial 58 exhaled nitric oxide 58 renal impairment 58 nonfatal stroke 58 systolic diastolic 58 intraventricular 58 diastolic pressures 58 intraocular inflammation 58 placebo 58 inotropic agents 58 left ventricular hypertrophy 58 hepatectomy 58 thickness CIMT 58 revascularisation 58 hemoglobin concentration 58 QoL 58 intraobserver 58 tHcy 58 adenotonsillectomy 58 endophthalmitis 58 MMSE 58 placebo fluoxetine 58 Percutaneous Coronary Intervention 58 aortic insufficiency 58 antithrombotic therapy 58 radical cystectomy 58 -#.# ± [002] 58 histologically confirmed 58 infarction 58 mg dose 58 lipid lowering agents 58 plus dexamethasone 58 hemodynamic 58 metabolic parameters 58 candesartan cilexetil 58 esophagectomy 58 histologic 58 arterial thickening 58 lymph node involvement 58 Systolic 58 vessel occlusion 58 CNS LS 58 peri procedural 58 radiographic progression 58 univariate 58 plasma HCV RNA 58 Elitek 58 NMIBC 58 mg BID dose 58 postoperative AF 58 natriuretic peptide 58 TEVAR 58 MetS 58 ventricular myocardium 58 pulmonary exacerbation 58 idraparinux 58 MIs 58 reperfusion 58 retransplantation 58 secondary efficacy endpoint 58 HIV RNA 58 postoperative 58 perfusion defects 58 dalteparin 58 plasma folate 58 progression TTP 58 events AEs 58 CRp 58 neurologic outcomes 58 g dl 58 ipsilateral 58 8mg/kg 58 insulin detemir 58 postoperative hemorrhage 58 Thal Dex 58 NIH CPSI 58 APTIVUS r 58 mitoxantrone 58 nonfasting triglycerides 58 salivary flow 58 melphalan prednisone 58 SLNB 58 decompensated heart failure 58 thickness IMT 58 prognostic factors 58 Scale EDSS 58 obstructive CAD 58 dapagliflozin plus 58 stage IIIb IV 58 Tumor shrinkage 58 reperfusion therapy 58 adjunctive ABILIFY 58 dimensional echocardiography 58 #.#/#.# mm Hg [001] 58 -#.# log# 58 μg liter 58 death reinfarction 58 International Prostate Symptom 58 serum testosterone levels 58 R0 resection 58 serum concentrations 58 Postoperatively 58 fasting triglyceride levels 58 RYGB 58 endoleak 58 mg ustekinumab 58 PANSS total 58 autonomic dysfunction 57 Kaplan Meier estimates 57 serum lipid levels 57 serum albumin 57 LMWH 57 â ‰ ¥ 57 Target Lesion Revascularization TLR 57 arteriography 57 aminotransferase levels 57 concomitant medications 57 hepatocellular carcinomas 57 rt PA 57 apolipoprotein B 57 MSCT 57 Index CDAI score 57 dysfunction LVSD 57 pressor response 57 parenchymal 57 ischemic 57 LEXIVA r 57 microbleeds 57 serum urate levels 57 mg QD 57 cytogenetic response 57 DCCT 57 pacemaker implantation 57 esomeprazole 57 #.#mmol L [002] 57 confidence intervals CIs 57 acute myocardial infarction AMI 57 diastolic pressure 57 cerebrovascular accident 57 XIENCE V demonstrated 57 hypogonadal men 57 TMC# r 57 elevated IOP 57 recurrent DVT 57 postoperative bleeding 57 severe mitral regurgitation 57 baseline FEV 57 sirolimus eluting stents 57 aortic root replacement 57 coronary calcification 57 serum aminotransferase levels 57 Median PFS 57 demonstrated clinically meaningful 57 sinus tachycardia 57 serum cortisol 57 ACR# responses 57 BENICAR 57 NYHA Class 57 atherosclerotic lesions 57 rheumatoid factor 57 CYPHER ® Stent 57 serum CRP 57 mg TID 57 calculated creatinine clearance 57 plasma cortisol 57 detrusor 57 plasma renin activity 57 DOXIL 57 vasopressor 57 dose atorvastatin 57 serum ferritin 57 atrioventricular block 57 HF hospitalization 57 tertiles 57 achieved PASI 57 airflow obstruction 57 ALT flares 57 infliximab monotherapy 57 multivariable adjusted 57 lopinavir r 57 flow mediated dilation 57 aminotransferase ALT 57 FluCAM arm 57 Diastolic 57 unresectable 57 intima media thickness IMT 57 undergoing CABG 57 coronary intervention 57 subclinical hyperthyroidism 57 hypokalemia 57 leucopenia 57 foveal thickness 57 platelet counts 57 thromboprophylaxis 57 ETDRS 57 carotid artery stenting CAS 57 artery stenosis 57 lymphocyte count 57 #mmHg [002] 57 baseline serum creatinine 57 sustained virologic response 57 upper gastrointestinal bleeding 57 postoperative chemotherapy 57 comorbidities 57 serum glucose 57 FluCAM 57 normothermic 57 antiarrhythmic drug 57 nondiabetics 57 multivariate Cox 57 β blocker 57 intravitreal injections 57 LV systolic dysfunction 57 macular thickness 57 intracoronary 57 levosimendan 57 serum cholesterol 57 sotalol 57 aspirin clopidogrel 57 lactate dehydrogenase 57 nadroparin 57 lower extremity amputation 57 timepoint 57 systolic blood pressure 57 cardiac dysfunction 57 ARIXTRA 57 transcranial Doppler 57 receiving prophylactic anticoagulation 57 peptide BNP 57 aldosterone antagonist 57 Adverse events 57 allopurinol 57 PREZISTA r 57 microvascular complications 57 fluorouracil 57 BPH Symptom Score 57 infliximab 57 Complication rates 57 trabeculectomy 57 complete cytogenetic 57 albumin excretion 57 XIENCE V vs. 57 ventricular fibrillation VF 57 coadministration 57 hypotension 57 neutrophil count 57 urine albumin 57 X ULN 57 IOP lowering 57 resected 57 statistically significant 57 ischemic lesions 57 revascularization procedure 57 functional mitral regurgitation 57 isolated systolic hypertension 57 fatal myocardial infarction 57 cystatin C 57 platelet inhibition 57 acute cholecystitis 57 venography 57 ramipril 57 cytoreductive surgery 57 urate lowering therapy 57 carotid artery thickness 57 elevated creatinine 57 stent binary restenosis 57 androgen deprivation 57 mRS 57 A1c 57 Scale EDSS score 57 intracranial hemorrhage ICH 57 prespecified secondary 57 postdose 57 receiving golimumab 57 prognostic variables 57 tacrolimus 57 underwent coronary angiography 57 colorectal carcinoma 57 mL sec 57 troponins 57 elective PCI 57 hypoglycemic events 57 primidone 57 nephron sparing surgery 57 gastric pH 57 stage IIIB 57 tipranavir r 57 infarct 57 blood Phe levels 57 rimonabant #mg 57 chlorthalidone 57 statistically significant p 57 biopsy Gleason 57 echogenicity 57 neurologic deficits